Arcturus Therapeutics Holdings Inc.
ARCT· Nasdaq
Released Nov 14, 2023, after the close
10-Q filed Nov 14, 2023, 45 days after period end · 0000950170-23-063778
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $45.14M | $13.37M | $2.44M | $2.33M |
| Net Income | -$16.22M | -$35.27M | -$54.08M | -$21.00M |
| EPS Diluted |
Arcturus Therapeutics Holdings Inc. · CIK 1768224 · Engraved from SEC EDGAR
| -$0.61 |
| -$1.33 |
| -$2.05 |
| -$0.92 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.